Live tape
Top 8, mentions 7d9,730TSLA2,009 mentions▲ +0.05GOOGL1,609 mentions▲ +0.05NVDA1,210 mentions▲ +0.07CRWV1,085 mentions▲ +0.03SPCX1,060 mentions▲ +0.07QQQ1,031 mentions▲ +0.04META881 mentions▲ +0.05MSFT845 mentions▲ +0.05

Equity · Healthcare

BLCO

NYSE

Bausch + Lomb Corporation

$16.48 −1.29% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 16, 2026
Price · Chart
64 sessions
$19 $15 20 Jul 16 Oct

The line runs $16 on 20 July through $16.48 on 16 October, on a scale from $15 to $19. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 64 sessions, 20 Jul – 16 Oct 2026
Market cap $5.9B
52-week range $14.32 – $18.60
Avg volume 37.3K

as of Oct 16, 2026

BLCO insider trades

SEC Form 4 · last 90 days · newest reported trade 10 Aug 2026
Open-market buys 0
Open-market sells 1
Net sold $888K
Non-trade filings 11
Date Insider Type Shares Value
10 Aug 2026 Munsch Frederick SVP, Controller and CAO Sell 52,900 $888K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
12 Aug 2026 Chersi Robert J Director Award 11,776
12 Aug 2026 PAUL LAURENCE E Director Award 11,776
12 Aug 2026 Trebbi Barbara Director Award 11,776
05 Aug 2026 Bailey A Robert D EVP & Chief Legal Officer Award 33,557
05 Aug 2026 SAUNDERS BRENT L Chairman of the Board and CEO Tax withheld 4,231 $71K
05 Aug 2026 SAUNDERS BRENT L Chairman of the Board and CEO Award 281,879
05 Aug 2026 Bonnefoy Luc President, Surgical Award 16,778
05 Aug 2026 Eldessouky Sam EVP and CFO Award 50,335
05 Aug 2026 Hashad Yehia EVP of R&D and CMO Award 20,973
05 Aug 2026 Munsch Frederick SVP, Controller and CAO Award 9,091
05 Aug 2026 Stewart Andrew J. President, GPIC Award 16,778

BLCO reported financials

SEC EDGAR XBRL SEC EDGAR

BLCO reported revenue of $5.1B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$360.0M.

Figure Reported Period
Revenue $5.1B 31 Dec 2025 fiscal year
Net income −$360.0M 31 Dec 2025 fiscal year
Diluted EPS −$1.02 31 Dec 2025 fiscal year
Total assets $13.9B 30 Jun 2026 at period end
Total equity $6.4B 30 Jun 2026 at period end

BLCO earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.04 $1.39B
31 Mar 2026 Q1 2026 −$0.20 $1.24B
31 Dec 2025 FY 2025 −$1.02 $5.10B
30 Sep 2025 Q3 2025 −$0.08 $1.28B
30 Jun 2025 Q2 2025 −$0.18 $1.28B
31 Mar 2025 Q1 2025 −$0.60 $1.14B
31 Dec 2024 FY 2024 −$0.90 $4.79B
30 Sep 2024 Q3 2024 $0.01 $1.20B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BLCO institutional holders

SEC Form 13F SEC EDGAR

14 of the 45 institutional funds we track reported a BLCO position for the quarter ended 30 Jun 2026 — a combined $238.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Carl Icahn Held (±25%) 3,500,000 $58.0M
Oaktree Capital Management Held (±25%) +1.7% shares 3,441,042 $57.0M
D. E. Shaw & Co. Held (±25%) +5.5% shares 3,323,021 $55.0M
Glenview Capital Management Held (±25%) +0.4% shares 1,918,148 $31.8M
Citadel Advisors Added +40.1% shares 987,730 $16.4M
Tudor Investment Corp Added +41.3% shares 532,030 $8.8M
Millennium Management Trimmed −41.7% shares 176,740 $2.9M
Point72 Asset Management Trimmed −37.9% shares 175,819 $2.9M
Third Point New position 85,000 $1.4M
Marshall Wace Held (±25%) +10.0% shares 70,257 $1.2M

Showing the 10 largest of 14 reported positions. The figures above count all of them.

BLCO fails-to-deliver

SEC CNS data SEC

On 29 Sep 2026, 30 shares of BLCO failed to deliver (about $509) — the latest of 3 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
29 Sep 2026 30 $509 <0.001%
28 Sep 2026 97 $2K <0.001%
25 Sep 2026 4 $67 <0.001%
23 Sep 2026 184 $3K <0.001%
22 Sep 2026 10 $168 <0.001%
18 Sep 2026 1,112 $19K <0.001%
17 Sep 2026 99 $2K <0.001%
14 Sep 2026 2,619 $45K 0.001%
09 Sep 2026 264 $5K <0.001%
08 Sep 2026 127 $2K <0.001%
04 Sep 2026 561 $10K <0.001%
03 Sep 2026 3,123 $56K 0.001%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings